Literature DB >> 11845257

Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cells.

Angela Märten1, Tim Greten, Carsten Ziske, Sabine Renoth, Björn Schöttker, Peter Buttgereit, Frank Schakowski, Alexander von Rücker, Tilman Sauerbruch, Ingo H Schmidt-Wolf.   

Abstract

Co-culturing of immunological effector cells with antigen-pulsed DC leads to an increase of cytotoxic activity against antigen-expressing tumour cells. Using this approach, we could detect up to 2.8% antigen-specific CTLs after co-culture with antigen-pulsed DC. However, the required high effector cell numbers remain a major obstacle in immunotherapy. In this study, we show an approach for generating activated and antigen-specific effector cells that enables us to decrease effector to target cell ratios. We used an interferon-gamma secretion assay to enrich activated effector cells after co-culture with antigen-pulsed dendritic cells (DC). Purified immunological effector cells lysed 58.3% of antigen-expressing tumour cells at an effector to target ratio of 1:1. Furthermore, using MHC-IgG complexes, we enriched effector cells expressing antigen-specific T-cell receptor after co-culture with DC. Performing ELISpot, flow cytometry and TCR analysis, we could show a significant increase of activated and specific TCR-expressing effector cells after co-culture with DC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11845257     DOI: 10.1007/s00262-001-0251-5

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  6 in total

1.  Pemetrexed plus dendritic cells as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer who had treatment with TKI.

Authors:  Rong-Hang Hu; Sheng-Bin Shi; Jie-Lin Qi; Jing Tian; Xiao-Yong Tang; Guo-Fang Liu; Chun-Xiao Chang
Journal:  Med Oncol       Date:  2014-06-24       Impact factor: 3.064

2.  Inhibition of JAK/STAT pathway restrains TSLP-activated dendritic cells mediated inflammatory T helper type 2 cell response in allergic rhinitis.

Authors:  Zhaohui Shi; Weihong Jiang; Min Wang; Xiaocheng Wang; Xiaoyuan Li; Xiaodong Chen; Li Qiao
Journal:  Mol Cell Biochem       Date:  2017-02-18       Impact factor: 3.396

3.  Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer.

Authors:  Srinivas Nagaraj; Carsten Ziske; Ingo Gh Schmidt-Wolf
Journal:  Genet Vaccines Ther       Date:  2004-08-25

4.  Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients.

Authors:  Daiqing Gao; Changyou Li; Xihe Xie; Peng Zhao; Xiaofang Wei; Weihong Sun; Hsin-Chen Liu; Aris T Alexandrou; Jennifer Jones; Ronghua Zhao; Jian Jian Li
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

5.  Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study.

Authors:  Ying Mu; Wei-Hua Wang; Jia-Ping Xie; Ying-Xin Zhang; Ya-Pei Yang; Chang-Hui Zhou
Journal:  Onco Targets Ther       Date:  2016-07-25       Impact factor: 4.147

6.  Cancer/testis antigens expression during cultivation of melanoma and soft tissue sarcoma cells.

Authors:  Anna Danilova; Vsevolod Misyurin; Aleksei Novik; Dmitry Girdyuk; Natalia Avdonkina; Tatiana Nekhaeva; Natalia Emelyanova; Nino Pipia; Andrey Misyurin; Irina Baldueva
Journal:  Clin Sarcoma Res       Date:  2020-02-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.